-
UTI Healthcare Fund Regular Plan Growth
Equity healthcare
Overview ( as on 09/06/26 )
NAV
₹311.31
Last change
₹3.5 +0.01%
Fund Size (AUM)
1143.58 Cr
Performance
14.25% (5Y)
Fund Details
UTI Healthcare Fund Regular Plan Growth
as of 09/06/26
AUM
1143.58 Cr
Expense Ratio
2.3 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01695
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Fund Regular Plan Growth | 10.87% | 26.3% | 14.25% |
| BSE Healthcare TR INR | 9.86% | 25.5% | 13.79% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
8.87% |
Divi's Laboratories Ltd |
4.87% |
Ajanta Pharma Ltd |
4.7% |
Gland Pharma Ltd |
3.98% |
Lupin Ltd |
3.8% |
Apollo Hospitals Enterprise Ltd |
3.56% |
Dr Reddy's Laboratories Ltd |
3.11% |
Caplin Point Laboratories Ltd |
3.08% |
Alkem Laboratories Ltd |
3.07% |
Fortis Healthcare Ltd |
3.05% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
94%
Equity
-
6%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
UTI Healthcare Fund
Equity healthcare-
Returns
-
14.25% (5Y)
-
-
UTI Healthcare IDCW-P Fund
Equity healthcare-
Returns
-
14.25% (5Y)
-
-
ICICI Pru Pharma Healthcare Diag Fund
Equity healthcare-
Returns
-
15.1% (5Y)
-
-
UTI Healthcare IDCW-R Fund
Equity healthcare-
Returns
-
13.76% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R Fund
Equity healthcare-
Returns
-
14.45% (5Y)
-
-
SBI Healthcare Opportunities Fund
Equity healthcare-
Returns
-
15.4% (5Y)
-
